James Harris says AI will raise client expectations and reward agents who deliver insights consumers cannot replicate, such as strong comps and tailored presentations. He also stresses tech agnostic ...

Abstract: Glaucoma, an irreversible neurodegenerative disorder, can lead to vision loss and blindness. Visual field (VF) tests are crucial for quantifying functional damage in glaucoma, but the tests ...

Members of the Danville-Pittsylvania Regional Industrial Facility Authority unanimously voted Monday to approve an agreement to sell property at the Southern Virginia Megasite at Berry Hill to SAC III ...

Amazon has confirmed that three Amazon Web Services (AWS) data centers in the United Arab Emirates (UAE) and one in Bahrain have been damaged by drone strikes, causing an extensive outage that is ...

Abstract: Two main challenges faced by deep learning systems are related to the amount of data and the complexity of the model concerning the number and type of layers and the number of training ...

All websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings ...

Blue Owl Capital-owned data center company Stack Infrastructure Inc. is seeking a loan of around A$3 billion ($2.1 billion), according to people familiar with the matter, as it accelerates development ...

Newsletter platform Substack has confirmed a data breach in an email to users. The company said that in October, an “unauthorized third party” accessed user data, including email addresses, phone ...

Many engineering teams still rely on architecture optimized for transactional apps, not for AI systems that mix structured and unstructured data and live event streams. This legacy architecture has ...

A Colorado-based company, Stack Infrastructure, plans to build a new data center in New Albany, Ohio. The new 300,000-square-foot facility will be built next to the company's existing data center.

Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...